SC-QDP measured the levels of pCRKL and pSTAT5, two surrogate markers of overactive BCR-ABL1 signaling, in single CD34+ cells in 5 new CML patients10, 24, 25. The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.